DeutschNewstral
Article
Forbes on 2022-02-07 14:20
Japan Could Fast Track Shionogi’s New Antiviral Pill To Treat Covid After Promising Trial Data
Related news
The hunt for an antiviral pill to treat COVID-19 at homenewatlas.com
FDA authorizes second antiviral pill to treat Covid-19San Jose Mercury News
UK authorizes Merck antiviral pill, first shown to treat COVID-19Fox News- FDA Approves Merck's Antiviral Pill For Emergency UseForbes
Administration Expands Availability of Covid Antiviral Pill Paxlovidlongislandpress.com
Merck Says Covid Antiviral Pill Is Effective in TrialThe New York Times- Merck Says Its Antiviral Pill Is Effective Against CovidThe New York Times
Pfizer Announces Licensing Agreement for Its Potential Coronavirus Antiviral Pillbreitbart.com- SMerck asks FDA to authorize promising pill to treat Covid-19syracuse.com
- TBiden set to announce US will double its order of Pfizer's antiviral pill to treat Covid-19tucson.com
Japan government panel approves first oral COVID-19 pillThe Japan Times- New COVID-19 oral antiviral approved for use in Japannewatlas.com
- U.S. Inks $1 Billion Deal For Extra Doses Of Merck’s Antiviral Covid PillForbes
Pfizer wants approval for promising COVID-19 pillreviewjournal.com- BMerck Says Its Covid-19 Antiviral Pill Looks Good Against Variants2 min readbarrons.com
- Merck Inks Deal To Share Antiviral Covid Pill With Poorer CountriesForbes
- EU Drug Regulator Backs Emergency Use Of Merck’s Covid Antiviral PillForbes
- Merck Says Trial Shows It Has Produced Effective Covid Antiviral PillThe New York Times
FDA authorizes first COVID-19 antiviral pillThe Verge
U.K. 1st country to authorize use of Merck's coronavirus antiviral pillCBC